CapsoVision (CV) Current Assets (2024 - 2025)
CapsoVision (CV) reported Current Assets of $16.7 million for Q4 2025, up 12.27% on a YoY basis from $14.8 million in Q4 2024, and down 30.68% sequentially from $24.0 million in Q3 2025.
CapsoVision (CV) Current Assets (2024 - 2025) Analysis & Trends
CapsoVision (CV) has 2 years of Current Assets data on file, last reported at $16.7 million in Q4 2025.
- For the quarter ending Q4 2025, Current Assets rose 12.27% year-over-year to $16.7 million; the trailing twelve-month figure through Dec 2025 stood at $16.7 million (up 12.27% YoY), and the FY2025 full-year result was $16.7 million, up 12.27% from the prior year.
- Current Assets declined to $16.7 million in Q4 2025, from $24.0 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $24.0 million in Q3 2025 to a low of $7.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 4.33 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 11.45 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.43 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 4.10 Bn |
| 10 | CapsoVision | 162.07 Mn | 151.95 Mn | 1.95 Mn | 16.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.67 Mn |
| Sep 30, 2025 | 24.05 Mn |
| Jun 30, 2025 | 7.80 Mn |
| Dec 31, 2024 | 14.85 Mn |